Загрузка...
Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
OBJECTIVE: Inaccessibility of the inflammation compartmentalized to the central nervous system (CNS) may underlie the lack of efficacy of immunomodulatory treatments in progressive multiple sclerosis (MS). The double blind combination of Rituximab by IntraVenous and IntraThecAl injection versus plac...
Сохранить в:
| Опубликовано в: : | Ann Clin Transl Neurol |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4774261/ https://ncbi.nlm.nih.gov/pubmed/27042677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.293 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|